Mr Daniel Joshua Wetherbee, LCPC | |
108 Old Solomons Island Rd, Unit 7, Annapolis, MD 21401-3845 | |
(410) 266-8345 | |
(410) 266-6278 |
Full Name | Mr Daniel Joshua Wetherbee |
---|---|
Gender | Male |
Speciality | Counselor - Professional |
Location | 108 Old Solomons Island Rd, Annapolis, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265778682 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | LC4799 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Daniel Joshua Wetherbee, LCPC 108 Old Solomons Island Rd, Unit 7, Annapolis, MD 21401-3845 Ph: (410) 266-8345 | Mr Daniel Joshua Wetherbee, LCPC 108 Old Solomons Island Rd, Unit 7, Annapolis, MD 21401-3845 Ph: (410) 266-8345 |
News Archive
Treatment with biphosphonates could prevent radiation-induced leukemia, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009.
The Texas Heart Institute (THI) at St. Luke's Episcopal Hospital has announced another major milestone in improved patient care, after performing its 1000th carotid artery stent procedure. Carotid artery stenting (CAS) has emerged as a less invasive treatment for stroke-causing blockages in the carotid artery, meaning patients generally have fewer risks for complications, shorter hospital stays and recovery times and less expense.
"IBS symptoms of abdominal pain or discomfort, bloating and constipation are associated with impaired quality of life and are the second most common cause of work-related absenteeism," according to Dr. Nigel Flook of the University of Alberta.
As the Medicare Model Guidelines-a listing of therapeutic categories and pharmacologic classes that Medicare Part D plans can utilize when developing their formularies-undergo revision for the first time in three years, the U.S. Pharmacopeial Convention (USP) is announcing its revision schedule and the expanded opportunities for public input as it develops Version 5.0.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.
› Verified 8 days ago
Jada Rogers, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 185 Admiral Cochrane Dr Ste 225, Annapolis, MD 21401 Phone: 443-440-5782 | |
Mrs. Shirley L Gordon, CAC, CMHT, CPRS Counselor Medicare: Not Enrolled in Medicare Practice Location: 92 W Washington St, Annapolis, MD 21401 Phone: 443-949-9545 Fax: 240-366-0055 | |
Ms. Marcia S Harrison, MMH, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1316 Forest Dr, Annapolis, MD 21403 Phone: 410-266-6884 Fax: 410-224-3423 | |
Mrs. Amy T. Masser, Counselor Medicare: Not Enrolled in Medicare Practice Location: 108 Old Solomons Island Rd, U7, Annapolis, MD 21401 Phone: 410-266-8345 Fax: 410-266-6278 | |
Ms. Nancy L Mccamish, LCPAT Counselor Medicare: Not Enrolled in Medicare Practice Location: 108 Old Solomons Island Rd, U7, Annapolis, MD 21401 Phone: 410-266-8345 Fax: 410-266-6278 | |
Dr. John Wirth, MS, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 102 Old Solomons Island Rd Ste 202, Annapolis, MD 21401 Phone: 410-266-3058 | |
Sarah Lynn Hern, LCSW-C Counselor Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1272 Fax: 443-481-1267 |